Seven-Day Continuous Abstinence Rate from Smoking at 1, 2, or 3 Years after the Use of Varenicline

Kim, Jin Se; Jang, Ju Young; Park, Eun Hye; Lee, Joo Young; Gu, Kang Mo; Jung, Jae Woo; Choi, Jae Chol; Shin, Jong Wook; Park, In Won; Choi, Byoung Whui; Kim, Jae Yeol

추천

검색

자료유형: 학술저널

저자정보: Kim, Jin Se (Department of Internal Medicine, Chung-Ang University College of Medicine) Jang, Ju Young (Department of Internal Medicine, Chung-Ang University College of Medicine) Park, Eun Hye (Department of Internal Medicine, Chung-Ang University College of Medicine) Lee, Joo Young (Department of Internal Medicine, Chung-Ang University College of Medicine) Gu, Kang Mo (Department of Internal Medicine, Chung-Ang University College of Medicine) Jung, Jae Woo (Department of Internal Medicine, Chung-Ang University College of Medicine) Choi, Jae Chol (Department of Internal Medicine, Chung-Ang University College of Medicine) Shin, Jong Wook (Department of Internal Medicine, Chung-Ang University College of Medicine) Park, In Won (Department of Internal Medicine, Chung-Ang University College of Medicine) Choi, Byoung Whui (Department of Internal Medicine, Chung-Ang University College of Medicine) Kim, Jae Yeol (Department of Internal Medicine, Chung-Ang University College of Medicine)

저널정보: 대한결핵 및 호흡기학회 Tuberculosis and Respiratory Diseases 결핵 및 호흡기 질환 제78권 제2호

발행연도: 2015.1

수록면: 92 - 98 (7page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Varenicline, a selective partial agonist/antagonist of the ${\alpha}4{\beta}2$ nicotinic receptor, has proven effectiveness for smoking cessation by several randomized, controlled trials. Because few studies have evaluated the long-term efficacy of varenicline, we tried to evaluate the smoking status of varenicline users up to 3 years after the initial prescription of the drug. Methods: We interviewed varenicline users who were prescribed the drug from June 2007 to May 2010 by telephone, from June 2010 to May 2011. Results: One-hundred and thirty-three of 250 varenicline users (53.2%) were available for the survey. Seven-day continuous abstinence from smoking was adhered to by 17 of 39 respondents (43.6%) at 1 year, and 11 of 36 (30.6%) and 19 of 58 (32.8%) at 2 and 3 years since the first use of varenicline, respectively. Compared to current smokers, successful quitters were older (55.0 years vs. 49.9 years, p=0.01), had better compliance to the 12-week course (27.7 vs. 9.3%, p=0.01), and had taken varenicline longer (10.1 vs. 5.9 weeks, p=0.01). Fifty-four of 71 current smokers (76.1%) were willing to stop smoking in the near future. The preferred ways to cease smoking were will-power (48.1%), varenicline (25.9%), nicotine replacement therapy (11.1%), and others (14.9%). Conclusion: Smokers should be encouraged to stick to the proven way for recommended period of time for successful cessation of smoking.

#Compliance #Smoking #Varenicline

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!